Abstract

Cancer is life-threatening disease. Surgical removal of tumors is an important procedure in early tumor treatment, and tumor imaging plays an important role in the treatment. Traditional tumor imaging often uses single-factor imaging, in which an enzyme was introduced into cancer cells to turn on the fluorescence of probes. This method, however, has disadvantages such as poor signal and strong interferences. We took advantage of the high GSH content and high viscosity of tumor cells to develop a new type of probe so-called TPQ-G. The developed TPQ-G probe relies on a cascade process. First, TPQ-G reacts with the highly expressed GSH in tumors to generate the fluorescent substance TPQ-OH, which can then be used to sense the high viscosity of the tumors. As a result, the fluorescence intensity was further enhanced, improving the effectiveness of the imaging.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.